The RED-C Studies were two clinical trials evaluating an investigational drug given twice daily, to see if it would help delay the first episode of overt hepatic encephalopathy requiring hospitalization in patients with liver cirrhosis. Bausch Health and PRA Health Sciences goal was to accelerate recruitment for this program using a suite of patient recruitment materials developed by the Stark / Raving Health team. Our approach focused on establishing a unique study brand identity combined with recruitment and educational materials that engaged and empowered patients to consider participation.